Jan 24, 2020 - J&J (JNJ) announces mixed Q4 results. Roche's (RHHBY) lymphoma drug, Polivy and Novartis' (NVS) Mayzent for secondary progressive multiple sclerosis (SPMS) get approval in Europe.
Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 23, 2020 - STMicroelectronics NV (NYSE:STM) Q4 2019 Earnings Conference Call January 23, 2020, 03:30 ET Company Participants Celine Berthier - Group VP, IR Jean-Marc - President & CEO Lorenzo Grandi - Presid
Sector: Health Care > Industry: Major Pharmaceuticals